PMMR/Ras/BRAF Wild-type
1 clinical trials · Condition
◉ Watch PMMR/Ras/BRAF Wild-type
| Record | Firm | Date |
|---|---|---|
| Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases (NCT05742425) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-03-01 |
Track PMMR/Ras/BRAF Wild-type automatically
Every clearance here is in the API, with alerts when new ones post.